Advancing Reproductive Health: Qualitative Methods & Interdisciplinary Mentorship

促进生殖健康:定性方法

基本信息

  • 批准号:
    8240777
  • 负责人:
  • 金额:
    $ 13.79万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2012
  • 资助国家:
    美国
  • 起止时间:
    2012-04-01 至 2017-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This midcareer investigator award (K24) will provide protected time, resources, and structure that will allow for a progression in my research career trajectory, from a primary focus on HIV prevention, to a more inclusive and extensive conceptualization of prevention in the broader context of sexual and reproductive health (SRH). Further, it will allow me to engage in a comprehensive process of mentorship in the use of mixed methodologies in patient-oriented research. My career development goals are to: 1) expand my knowledge and expertise from HIV prevention alone to a more inclusive focus on sexual and reproductive health, 2) advance an expanded research agenda into the development of effective sexual and reproductive health technologies and interventions, and 3) advance my scholarly role in the use of mixed methods research for health promotion sciences by mentoring fellows and junior investigators in patient oriented research. The proposed mentorship plan will allow me to dedicate the necessary time and effort to fully integrate a comprehensive mixed methods research training program into my mentoring of junior investigators. The proposed research will provide the context for mentoring those investigators. The structured mentorship program will allow me to provide scientific leadership and in-depth methodological training for junior investigators interested in prevention intervention and treatment evaluation research. Through this mentorship in state-of-the-science mixed methods, I will promote the conduct of rigorous health promotion research across a wide range of health promotion sciences. My midcareer development plan will allow me to pursue learning and research activities that broaden my knowledge base and expertise into SRH and help me to better understand user experiences with SRH technologies, and identify those factors that impact use. Critical to use is "acceptability." However, current conceptualizations of adherence and acceptability fail to fully articulate and account for patterns of use and non-use. I propose that a new model of use, "Effective Use," is required, and propose the conduct of a longitudinal prospective mixed methods study to articulate this model. The concept of "Effective Use" begins with an inherent demand for the best user experience. It holds that a user's positive experience drives use, and that because use is maintained by this positive experience, higher exposure to the biomedical intervention (e.g., active ingredient), whether for prevention or treatment, is achieved. Relevance to Public Health: Sexual and reproductive health is a global public health priority. Providing efficacious SRH technologies that have the greatest likelihood of use will have the greatest impact on women's health. If successful, an Effective Use model would offer a new paradigm for the development of sexual and reproductive health technologies for women and their partners that will result in increased use and improved sexual and reproductive health outcomes. PUBLIC HEALTH RELEVANCE: This K24 award will provide me with protected time to conduct mixed methods research that will articulate a new paradigm for the development of sexual and reproductive health technologies: specific to my research, our ability to develop technologies that have the greatest likelihood of use will have the greatest impact on women's sexual and reproductive health, a global public health priority. The K24 award will also allow time to implement a comprehensive mixed methods mentorship program to train a new cadre of researchers in the health promotion sciences
描述(由申请人提供):这一职业生涯中期调查人员奖(K24)将提供受保护的时间、资源和结构,使我的研究职业轨迹能够从主要关注艾滋病毒预防,到在性健康和生殖健康(SRH)的更广泛的背景下更具包容性和更广泛的预防概念。此外,它将使我能够在以患者为导向的研究中使用混合方法进行全面的指导过程。我的职业发展目标是:1)将我的知识和专业知识从单纯的艾滋病毒预防扩展到更具包容性的关注性健康和生殖健康;2)推进扩大的研究议程,发展有效的性健康和生殖健康技术和干预措施;3)通过指导以患者为导向的研究中的研究员和初级调查人员,提高我在使用混合方法研究健康促进科学方面的学术作用。拟议的指导计划将使我能够投入必要的时间和努力,将全面的混合方法研究培训计划完全整合到我对初级调查人员的指导中。拟议的研究将为指导这些调查人员提供背景。结构化的指导计划将使我能够为对预防干预和治疗评估研究感兴趣的初级研究人员提供科学领导和深入的方法学培训。通过这种最先进的混合方法的指导,我将促进在广泛的健康促进科学中进行严格的健康促进研究。我的职业生涯中期发展计划将使我能够从事学习和研究活动,扩大我对SRH的知识基础和专业知识,并帮助我更好地了解SRH技术的用户体验,并确定那些影响使用的因素。使用的关键是“可接受性”。然而,目前对遵守和可接受性的概念化未能充分阐明和解释使用和不使用的模式。我提出了一种新的使用模式--“有效使用”,并建议进行纵向前瞻性混合方法研究来阐明这一模式。“有效使用”的概念始于对最佳用户体验的内在需求。它认为,用户的积极体验推动了使用,由于使用是通过这种积极体验来维持的,因此无论是用于预防还是治疗,都可以更高地接触到生物医学干预(例如,活性成分)。与公共卫生的相关性:性健康和生殖健康是全球公共卫生优先事项。提供最有可能使用的有效的SRH技术将对妇女的健康产生最大的影响。如果成功,有效的使用模式将为妇女及其伴侣发展性健康和生殖健康技术提供一个新的范例,从而增加使用并改进性健康和生殖健康的结果。 与公共健康相关:这个K24奖项将为我提供进行混合方法研究的保护时间,这些研究将阐明开发性健康和生殖健康技术的新范式:就我的研究而言,我们开发最有可能使用的技术的能力将对女性的性健康和生殖健康产生最大的影响,这是全球公共卫生的优先事项。K24奖还将允许有时间实施全面的混合方法指导计划,以培训健康促进科学领域的新一批研究人员。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Kate M Guthrie其他文献

Kate M Guthrie的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Kate M Guthrie', 18)}}的其他基金

Advancing Reproductive Health: Qualitative Methods & Interdisciplinary Mentorship
促进生殖健康:定性方法
  • 批准号:
    8823641
  • 财政年份:
    2012
  • 资助金额:
    $ 13.79万
  • 项目类别:
Advancing Reproductive Health: Qualitative Methods & Interdisciplinary Mentorship
促进生殖健康:定性方法
  • 批准号:
    8637097
  • 财政年份:
    2012
  • 资助金额:
    $ 13.79万
  • 项目类别:
Advancing Reproductive Health: Qualitative Methods & Interdisciplinary Mentorship
促进生殖健康:定性方法
  • 批准号:
    8451362
  • 财政年份:
    2012
  • 资助金额:
    $ 13.79万
  • 项目类别:
Evaluating User Perceptions and Experience of Dual Compartment Microbicide Form.
评估用户对双室杀菌剂形式的看法和体验。
  • 批准号:
    8404977
  • 财政年份:
    2012
  • 资助金额:
    $ 13.79万
  • 项目类别:
Preclinical User Accptability Studies Long Acting Vaginal Gels, Intravaginal Ring
长效阴道凝胶、阴道环的临床前用户可接受性研究
  • 批准号:
    7418070
  • 财政年份:
    2008
  • 资助金额:
    $ 13.79万
  • 项目类别:
Linking Biophysical Functions of Microbicides to User Perception & Acceptability
将杀菌剂的生物物理功能与用户感知联系起来
  • 批准号:
    7513361
  • 财政年份:
    2006
  • 资助金额:
    $ 13.79万
  • 项目类别:
Linking Biophysical Functions of Microbicides to User Perception & Acceptability
将杀菌剂的生物物理功能与用户感知联系起来
  • 批准号:
    7684100
  • 财政年份:
    2006
  • 资助金额:
    $ 13.79万
  • 项目类别:
Linking Biophysical Functions of Microbicides to User Perception & Acceptability
将杀菌剂的生物物理功能与用户感知联系起来
  • 批准号:
    7921125
  • 财政年份:
    2006
  • 资助金额:
    $ 13.79万
  • 项目类别:
Linking Biophysical Functions of Microbicides to User Perception & Acceptability
将杀菌剂的生物物理功能与用户感知联系起来
  • 批准号:
    7932824
  • 财政年份:
    2006
  • 资助金额:
    $ 13.79万
  • 项目类别:
Evaluating User Perceptions and Experience of Dual Compartment Microbicide Form.
评估用户对双室杀菌剂形式的看法和体验。
  • 批准号:
    8699501
  • 财政年份:
  • 资助金额:
    $ 13.79万
  • 项目类别:

相似海外基金

Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 13.79万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mighty Accounting - Accountancy Automation for 1-person limited companies.
Mighty Accounting - 1 人有限公司的会计自动化。
  • 批准号:
    10100360
  • 财政年份:
    2024
  • 资助金额:
    $ 13.79万
  • 项目类别:
    Collaborative R&D
Accounting for the Fall of Silver? Western exchange banking practice, 1870-1910
白银下跌的原因是什么?
  • 批准号:
    24K04974
  • 财政年份:
    2024
  • 资助金额:
    $ 13.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
CPS: Medium: Making Every Drop Count: Accounting for Spatiotemporal Variability of Water Needs for Proactive Scheduling of Variable Rate Irrigation Systems
CPS:中:让每一滴水都发挥作用:考虑用水需求的时空变化,主动调度可变速率灌溉系统
  • 批准号:
    2312319
  • 财政年份:
    2023
  • 资助金额:
    $ 13.79万
  • 项目类别:
    Standard Grant
A New Direction in Accounting Education for IT Human Resources
IT人力资源会计教育的新方向
  • 批准号:
    23K01686
  • 财政年份:
    2023
  • 资助金额:
    $ 13.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An empirical and theoretical study of the double-accounting system in 19th-century American and British public utility companies
19世纪美国和英国公用事业公司双重会计制度的实证和理论研究
  • 批准号:
    23K01692
  • 财政年份:
    2023
  • 资助金额:
    $ 13.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
An Empirical Analysis of the Value Effect: An Accounting Viewpoint
价值效应的实证分析:会计观点
  • 批准号:
    23K01695
  • 财政年份:
    2023
  • 资助金额:
    $ 13.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Accounting model for improving performance on the health and productivity management
提高健康和生产力管理绩效的会计模型
  • 批准号:
    23K01713
  • 财政年份:
    2023
  • 资助金额:
    $ 13.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
New Role of Not-for-Profit Entities and Their Accounting Standards to Be Unified
非营利实体的新角色及其会计准则将统一
  • 批准号:
    23K01715
  • 财政年份:
    2023
  • 资助金额:
    $ 13.79万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Improving Age- and Cause-Specific Under-Five Mortality Rates (ACSU5MR) by Systematically Accounting Measurement Errors to Inform Child Survival Decision Making in Low Income Countries
通过系统地核算测量误差来改善特定年龄和特定原因的五岁以下死亡率 (ACSU5MR),为低收入国家的儿童生存决策提供信息
  • 批准号:
    10585388
  • 财政年份:
    2023
  • 资助金额:
    $ 13.79万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了